RxDoctor Payments Data

Christopher Acevedo-Ramos, PA

Medical · Miami, FLNPI 1407535008

Payments from drug & device makers

$1,271in general payments, 2019–2025

Across 65 payments — averaging $19.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$259
  • Novo Nordisk$201
  • Exact Sciences$195
  • Lilly USA, LLC$107
  • Boehringer Ingelheim$76
  • AbbVie$71
  • plus $363 from 11 others

What the payments were for

  • Food & beverage$1,271100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,271 in reported general payments places this provider in the 60th percentile of 2,031 medical providers in Florida.

See all medical providers in Florida

Medicare billing

Part B allowed, 2024
$3,741
Medicare patients
17
Services billed
40

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin13$14,310
Omega-3 Acid Ethyl Esters16$687
Albuterol Sulfate HfaAlbuterol Sulfate19$453
Rosuvastatin Calcium22$299
Metoprolol Succinate18$246
Atorvastatin Calcium19$176
Losartan Potassium16$95
Alendronate Sodium11$53
Amlodipine Besylate22$45
Metformin Hcl ErMetformin Hcl13$26

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$76$14,31013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,031 medical providers in Florida.

Other medical in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →